132 related articles for article (PubMed ID: 36055955)
1. Epidemiology and outcome of anaerobic bacteremia in a tertiary hospital.
Zouggari Y; Lelubre C; Lali SE; Cherifi S
Eur J Intern Med; 2022 Nov; 105():63-68. PubMed ID: 36055955
[TBL] [Abstract][Full Text] [Related]
2. Short-term culture for rapid identification of anaerobic bacteria from blood cultures.
Rassolie A; Özenci V
Anaerobe; 2019 Jun; 57():59-62. PubMed ID: 30926438
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and microbiological features of anaerobic bacteremia in two French University hospitals.
Dumont Y; Bonzon L; Michon AL; Carriere C; Didelot MN; Laurens C; Renard B; Veloo ACM; Godreuil S; Jean-Pierre H
Anaerobe; 2020 Aug; 64():102207. PubMed ID: 32360436
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and antimicrobial susceptibilities of anaerobic bacteremia in an acute care hospital.
Tan TY; Ng LS; Kwang LL; Rao S; Eng LC
Anaerobe; 2017 Feb; 43():69-74. PubMed ID: 27890724
[TBL] [Abstract][Full Text] [Related]
5. Are incidence and epidemiology of anaerobic bacteremia really changing?
Vena A; Muñoz P; Alcalá L; Fernandez-Cruz A; Sanchez C; Valerio M; Bouza E
Eur J Clin Microbiol Infect Dis; 2015 Aug; 34(8):1621-9. PubMed ID: 26017663
[TBL] [Abstract][Full Text] [Related]
6. A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital.
Blairon L; De Gheldre Y; Delaere B; Sonet A; Bosly A; Glupczynski Y
Clin Microbiol Infect; 2006 Jun; 12(6):527-32. PubMed ID: 16700700
[TBL] [Abstract][Full Text] [Related]
7. Anaerobic bacteremia: incidence, patient characteristics, and clinical significance.
Lombardi DP; Engleberg NC
Am J Med; 1992 Jan; 92(1):53-60. PubMed ID: 1731510
[TBL] [Abstract][Full Text] [Related]
8. Community-acquired anaerobic bacteremia in adults: one-year experience in a medical center.
Hung MN; Chen SY; Wang JL; Chang SC; Hsueh PR; Liao CH; Chen YC
J Microbiol Immunol Infect; 2005 Dec; 38(6):436-43. PubMed ID: 16341345
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance and outcomes of Clostridium perfringens bacteremia--a 10-year experience at a tertiary care hospital.
Yang CC; Hsu PC; Chang HJ; Cheng CW; Lee MH
Int J Infect Dis; 2013 Nov; 17(11):e955-60. PubMed ID: 23578849
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for mortality in patients with anaerobic bacteremia.
Wilson JR; Limaye AP
Eur J Clin Microbiol Infect Dis; 2004 Apr; 23(4):310-6. PubMed ID: 15024626
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy.
Kim YJ; Jun YH; Kim YR; Park KG; Park YJ; Kang JY; Kim SI
BMC Infect Dis; 2014 Mar; 14():161. PubMed ID: 24655422
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics associated with mortality of patients with anaerobic bacteremia.
Umemura T; Hamada Y; Yamagishi Y; Suematsu H; Mikamo H
Anaerobe; 2016 Jun; 39():45-50. PubMed ID: 26903282
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of anaerobic bacteremias in a general hospital. A prospective study from 1988 to 1992.
Gómez J; Baños V; Ruiz J; Herrero F; Pérez M; Pretel L; Canteras M; Valdés M
Clin Investig; 1993 Aug; 71(8):595-9. PubMed ID: 8219651
[TBL] [Abstract][Full Text] [Related]
14. Anaerobic bacteraemia: a 10-year retrospective epidemiological survey.
De Keukeleire S; Wybo I; Naessens A; Echahidi F; Van der Beken M; Vandoorslaer K; Vermeulen S; Piérard D
Anaerobe; 2016 Jun; 39():54-9. PubMed ID: 26923749
[TBL] [Abstract][Full Text] [Related]
15. Gram-negative bacilli bacteremia: a 7 year retrospective study in a referral Brazilian tertiary-care teaching hospital.
Quillici MCB; Resende DS; Gonçalves IR; Royer S; Sabino SS; Almeida VF; Ribas RM; Gontijo Filho PP
J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33258755
[No Abstract] [Full Text] [Related]
16. Anaerobic blood culture positivity at a University Hospital in Hungary: A 5-year comparative retrospective study.
Gajdács M; Ábrók M; Lázár A; Terhes G; Urbán E
Anaerobe; 2020 Jun; 63():102200. PubMed ID: 32247001
[TBL] [Abstract][Full Text] [Related]
17. Fusobacterium bacteremia: clinical significance and outcomes.
Su CP; Huang PY; Yang CC; Lee MH
J Microbiol Immunol Infect; 2009 Aug; 42(4):336-42. PubMed ID: 19949758
[TBL] [Abstract][Full Text] [Related]
18. Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae.
Falcone M; Bassetti M; Tiseo G; Giordano C; Nencini E; Russo A; Graziano E; Tagliaferri E; Leonildi A; Barnini S; Farcomeni A; Menichetti F
Crit Care; 2020 Jan; 24(1):29. PubMed ID: 32000834
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and impact of antibiotherapy in 117 cases of anaerobic bacteraemia.
Robert R; Deraignac A; Le Moal G; Ragot S; Grollier G
Eur J Clin Microbiol Infect Dis; 2008 Aug; 27(8):671-8. PubMed ID: 18357478
[TBL] [Abstract][Full Text] [Related]
20. Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-β-lactamase-producing bacteria.
Frakking FN; Rottier WC; Dorigo-Zetsma JW; van Hattem JM; van Hees BC; Kluytmans JA; Lutgens SP; Prins JM; Thijsen SF; Verbon A; Vlaminckx BJ; Cohen Stuart JW; Leverstein-van Hall MA; Bonten MJ
Antimicrob Agents Chemother; 2013 Jul; 57(7):3092-9. PubMed ID: 23612198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
